THE HEALTH RELATED QUALITY OF LIFE DATA (HRQOL) FOR HEALTH TECHNOLOGY ASSESSMENT (HTA) PROCESS IN EUROPE: THEIR UTILIZATION AND IMPACT ON OPINIONS ACROSS HTA AGENCIES

被引:0
|
作者
Stamenkovic, S. [1 ]
机构
[1] Haute Autorite Sante, La Plaine St Denis, France
关键词
D O I
10.1016/j.jval.2011.08.1280
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A467 / A467
页数:1
相关论文
共 50 条
  • [1] COMPARISON OF HEALTH TECHNOLOGY ASSESSMENT (HTA) RANKINGS BY GERMAN AND FRENCH HTA AGENCIES
    Hu, I
    Zheng, J.
    Hu, X. H.
    VALUE IN HEALTH, 2015, 18 (03) : A96 - A97
  • [2] Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe
    Loblova, Olga
    HEALTH ECONOMICS POLICY AND LAW, 2016, 11 (03) : 253 - 273
  • [3] Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies
    Makady, Amr
    ten Ham, Renske
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    VALUE IN HEALTH, 2017, 20 (04) : 520 - 532
  • [4] Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
    Makady, Amr
    van Veelen, Ard
    Jonsson, Pall
    Moseley, Owen
    D'Andon, Anne
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    PHARMACOECONOMICS, 2018, 36 (03) : 359 - 368
  • [5] Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
    Amr Makady
    Ard van Veelen
    Páll Jonsson
    Owen Moseley
    Anne D’Andon
    Anthonius de Boer
    Hans Hillege
    Olaf Klungel
    Wim Goettsch
    PharmacoEconomics, 2018, 36 : 359 - 368
  • [6] The use of Real-World Data (RWD) by Health Technology Assessment (HTA) agencies
    Karen, K.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 218 - 218
  • [7] Using real-world data (RWD) in health technology assessment (HTA) practice: A comparative study of 5 HTA agencies
    Makady, Amr
    van Veelen, Ard
    Jonsson, Pall
    Moseley, Owen
    D'Andon, Anne
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 91 - 91
  • [8] USING REAL-WORLD DATA (RWD) IN HEALTH TECHNOLOGY ASSESSMENT (HTA) PRACTICE: A COMPARATIVE STUDY OF 5 HTA AGENCIES
    Makady, A.
    van Veelen, A.
    Jonsson, P.
    Moseley, O.
    D'Andon, A.
    de Boer, A.
    Hillege, J. L.
    Klungel, O.
    Goettsch, W.
    VALUE IN HEALTH, 2017, 20 (09) : A401 - A401
  • [9] SEGMENTATION OF SEVEN ASIA-PACIFIC HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES INTO DIFFERENT EVOLUTIONARY HTA ARCHETYPES
    Mazumder, D.
    Kapoor, A.
    Gwatkin, N.
    Medeiros, C.
    VALUE IN HEALTH, 2016, 19 (07) : A832 - A832
  • [10] GLOBAL ONCOLOGY ACCESS - THE RELATIVE DIFFICULTY OF REIMBURSEMENT ACROSS FOUR HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES
    Nguyen, K.
    Forsythe, A.
    Azimpour, K.
    Vu, B. K.
    Tomaras, D.
    VALUE IN HEALTH, 2020, 23 : S68 - S68